Stereotaxis EBITDA Margin 2010-2024 | STXS
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Stereotaxis (STXS) over the last 10 years. The current EBITDA margin for Stereotaxis as of December 31, 2024 is .
| Stereotaxis EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2024-12-31 |
$0.03B |
$-0.02B |
-88.89% |
| 2024-09-30 |
$0.03B |
$-0.02B |
-84.62% |
| 2024-06-30 |
$0.03B |
$-0.02B |
-84.00% |
| 2024-03-31 |
$0.03B |
$-0.02B |
-71.43% |
| 2023-12-31 |
$0.03B |
$-0.02B |
-75.00% |
| 2023-09-30 |
$0.03B |
$-0.02B |
-66.67% |
| 2023-06-30 |
$0.03B |
$-0.02B |
-66.67% |
| 2023-03-31 |
$0.03B |
$-0.02B |
-71.43% |
| 2022-12-31 |
$0.03B |
$-0.02B |
-64.29% |
| 2022-09-30 |
$0.03B |
$-0.02B |
-58.62% |
| 2022-06-30 |
$0.03B |
$-0.02B |
-56.67% |
| 2022-03-31 |
$0.03B |
$-0.02B |
-45.45% |
| 2021-12-31 |
$0.04B |
$-0.01B |
-37.14% |
| 2021-09-30 |
$0.03B |
$-0.01B |
-32.35% |
| 2021-06-30 |
$0.03B |
$-0.01B |
-23.53% |
| 2021-03-31 |
$0.03B |
$-0.01B |
-23.33% |
| 2020-12-31 |
$0.03B |
$-0.01B |
-25.93% |
| 2020-09-30 |
$0.03B |
$-0.01B |
-25.93% |
| 2020-06-30 |
$0.03B |
$-0.01B |
-19.23% |
| 2020-03-31 |
$0.03B |
$0.00B |
-14.29% |
| 2019-12-31 |
$0.03B |
$0.00B |
-13.79% |
| 2019-09-30 |
$0.03B |
$0.00B |
-10.34% |
| 2019-06-30 |
$0.03B |
$0.00B |
-10.34% |
| 2019-03-31 |
$0.03B |
0 |
0.00% |
| 2018-12-31 |
$0.03B |
$0.00B |
-6.67% |
| 2018-09-30 |
$0.03B |
$-0.01B |
-19.35% |
| 2018-06-30 |
$0.03B |
$-0.01B |
-19.35% |
| 2018-03-31 |
$0.03B |
$-0.01B |
-25.81% |
| 2017-12-31 |
$0.03B |
$-0.01B |
-19.35% |
| 2017-09-30 |
$0.03B |
$0.00B |
-13.33% |
| 2017-06-30 |
$0.03B |
$-0.01B |
-16.67% |
| 2017-03-31 |
$0.03B |
$-0.01B |
-23.33% |
| 2016-12-31 |
$0.03B |
$-0.01B |
-18.75% |
| 2016-09-30 |
$0.03B |
$0.00B |
-11.76% |
| 2016-06-30 |
$0.04B |
$-0.01B |
-14.29% |
| 2016-03-31 |
$0.04B |
$-0.01B |
-13.51% |
| 2015-12-31 |
$0.04B |
$0.00B |
-10.53% |
| 2015-09-30 |
$0.04B |
$-0.01B |
-12.82% |
| 2015-06-30 |
$0.04B |
$-0.01B |
-15.38% |
| 2015-03-31 |
$0.04B |
$-0.01B |
-16.22% |
| 2014-12-31 |
$0.04B |
$-0.01B |
-22.86% |
| 2014-09-30 |
$0.03B |
$-0.06B |
-164.71% |
| 2014-06-30 |
$0.04B |
$0.00B |
-2.78% |
| 2014-03-31 |
$0.04B |
$0.00B |
2.63% |
| 2013-12-31 |
$0.04B |
$0.00B |
2.63% |
| 2013-09-30 |
$0.04B |
$0.05B |
124.39% |
| 2013-06-30 |
$0.04B |
$0.00B |
-2.38% |
| 2013-03-31 |
$0.04B |
$0.00B |
-9.30% |
| 2012-12-31 |
$0.05B |
$-0.01B |
-10.64% |
| 2012-09-30 |
$0.05B |
$-0.01B |
-21.28% |
| 2012-06-30 |
$0.04B |
$-0.02B |
-40.91% |
| 2012-03-31 |
$0.05B |
$-0.02B |
-53.33% |
| 2011-12-31 |
$0.04B |
$-0.03B |
-67.44% |
| 2011-09-30 |
$0.05B |
$-0.03B |
-58.70% |
| 2011-06-30 |
$0.05B |
$-0.02B |
-43.14% |
| 2011-03-31 |
$0.05B |
$-0.02B |
-33.33% |
| 2010-12-31 |
$0.06B |
$-0.02B |
-27.27% |
| 2010-09-30 |
$0.05B |
$-0.02B |
-31.48% |
| 2010-06-30 |
$0.05B |
$-0.02B |
-32.08% |
| 2010-03-31 |
$0.05B |
$-0.02B |
-33.33% |
| 2009-12-31 |
$0.05B |
$-0.02B |
-35.29% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED INSTRUMENTS |
$0.174B |
$0.027B |
|
Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Stereotaxis System is designed to allow physicians to navigate catheters, guidewires and stent delivery devices through the blood vessels and chambers of the heart to treatment sites.
|
